Innate Pharma(股票代碼IPHA)股價財報分析

Innate Pharma SA is a biopharmaceutical company, which engages in improving oncology treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. Its product pipeline include Lacutamab, Monalizumab, Avdoralimab, and IPH62. The company was founded by Herv? Eloi Dominique Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fourni?, and Fran鏾is Romagn? on September 23, 1999 and is headquartered in Marseille, France.

Innate Pharma股票代碼IPHA,員工數量215人,成立日期:10/17/2019。

0

评论0

请先
没有账号?注册  忘记密码?